IGF-IRα/β shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemIGF-IRα/β shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-29358-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Nameinsulin like growth factor 1 receptor
NCBI Gene AliasesCD221, IGFIR, IGFR, JTK13

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) IPF pathogenesis is dependent upon TGFβ induction of IGF-1FASEB journal : official publication of the Federation of American Societies for Experimental BiologyApril 1, 2020Hernandez DM, Kang JH, Choudhury M, Andrianifahanana M, Yin X, Limper AH, Leof EB.

(2) Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cellsOncogeneJuly 1, 2019Zhu S, Soutto M, Chen Z, Blanca Piazuelo M, Kay Washington M, Belkhiri A, Zaika A, Peng D, El-Rifai W.

(3) Growth Hormone Induces Colon DNA Damage Independent of IGF-1EndocrinologyJune 1, 2019Chesnokova V, Zonis S, Barrett RJ, Gleeson JP, Melmed S.

(4) Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer CellsIranian biomedical journalJanuary 1, 2019Jafari R, Majidi Zolbanin N, Majidi J, Atyabi F, Yousefi M, Jadidi-Niaragh F, Aghebati-Maleki L, Shanehbandi D, Soltani Zangbar MS, Rafatpanah H.

(5) Metformin Induces Apoptosis and Inhibits Proliferation through the AMP-Activated Protein Kinase and Insulin-like Growth Factor 1 Receptor Pathways in the Bile Duct Cancer CellsJournal of CancerJanuary 1, 2019Lee J, Hong EM, Kim JH, Jung JH, Park SW, Koh DH, Choi MH, Jang HJ, Kae SH.

(6) Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell lineArtificial cells, nanomedicine, and biotechnologyMarch 1, 2018Shali H, Shabani M, Pourgholi F, Hajivalili M, Aghebati-Maleki L, Jadidi-Niaragh F, Baradaran B, Movassaghpour Akbari AA, Younesi V, Yousefi M.

(7) IGF1R(+) Dental Pulp Stem Cells Enhanced Neuroplasticity in Hypoxia-Ischemia ModelMolecular neurobiologyDecember 1, 2017Chiu HY, Lin CH, Hsu CY, Yu J, Hsieh CH, Shyu WC.

(8) Assessment of GSK1904529A as a promising anti-osteosarcoma agentOncotargetJuly 25, 2017Fei HD, Yuan Q, Mao L, Chen FL, Cui ZH, Tao S, Ji F.

(9) MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancerTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineJune 1, 2017Pang H, Yue X.

(10) Role of IGF1R(+) MSCs in modulating neuroplasticity via CXCR4 cross-interactionScientific reportsSeptember 2, 2016Lee HT, Chang HT, Lee S, Lin CH, Fan JR, Lin SZ, Hsu CY, Hsieh CH, Shyu WC.

(11) Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cellsOncotargetAugust 2, 2016Zovko A, Novak M, Hååg P, Kovalerchick D, Holmlund T, Färnegårdh K, Ilan M, Carmeli S, Lewensohn R, Viktorsson K.

(12) Low Oxygen Tension Modulates the Insulin-Like Growth Factor-1 or -2 Signaling via Both Insulin-Like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem CellsEndocrinologyMarch 1, 2016Youssef A, Han VK.

(13) Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemiaBloodAugust 29, 2013Yaktapour N, Übelhart R, Schüler J, Aumann K, Dierks C, Burger M, Pfeifer D, Jumaa H, Veelken H, Brummer T, et al.

(14) The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathwayThe Journal of biological chemistryMarch 22, 2013Singh D, Qi R, Jordan JL, San Mateo L, Kao CC.

(15) Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancerCancer researchMarch 15, 2013Tahir SA, Yang G, Goltsov A, Song KD, Ren C, Wang J, Chang W, Thompson TC.

(16) IGF-I enhances α5β1 integrin expression and cell motility in human chondrosarcoma cellsJournal of cellular physiologyDecember 1, 2011Wu CM, Li TM, Hsu SF, Su YC, Kao ST, Fong YC, Tang CH.

(17) Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cellsGrowth factors (Chur, Switzerland)April 1, 2011Richardson AE, Hamilton N, Davis W, Brito C, De León D.

(18) Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cellsThe Journal of biological chemistryFebruary 25, 2011Zhao D, Bakirtzi K, Zhan Y, Zeng H, Koon HW, Pothoulakis C.

(19) Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitroGrowth factors (Chur, Switzerland)February 1, 2007Cosaceanu D, Carapancea M, Alexandru O, Budiu R, Martinsson HS, Starborg M, Vrabete M, Kanter L, Lewensohn R, Dricu A.

Be the First to Write a Review!

IGF-IRα/β shRNA Plasmid (h)

IGF-IRα/β shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

Citations (19)

Reviews

IGF-IRα/β shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map